Human Umbilical Cord Mesenchymal Stem Cell Transplantation in Articular Cartilage Defect

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

July 31, 2016

Study Completion Date

December 31, 2016

Conditions
Cartilage DiseasesOsteoarthritis
Interventions
BIOLOGICAL

Human umbilical cord mesenchymal stem cells

A single dose of 2×107 hUC-MSC will be implanted to patients by intra-articular injection, and repeated every month for four times.

Trial Locations (1)

510000

The Fifth Affiliated Hospital Immunotherapy center, Guangzhou

All Listed Sponsors
collaborator

Fifth Affiliated Hospital of Guangzhou Medical University

OTHER

lead

Shenzhen Hornetcorn Bio-technology Company, LTD

INDUSTRY

NCT02291926 - Human Umbilical Cord Mesenchymal Stem Cell Transplantation in Articular Cartilage Defect | Biotech Hunter | Biotech Hunter